BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Bleomycin
,
rs2230926
,
LEP
,
Metabolism of xenobiotics
,
Hepatitis
,
Retina
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD105
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Microglial cell
Heart atrium
Lung
Heart ventricle
Spleen
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Osler hemorrhagic telangiectasia syndrome
Placental insufficiency
Poisoning by drug AND/OR medicinal substance
Disease due to Orthopoxvirus
Toxic nephropathy
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Viral Vaccines
RPI-1 cpd
CL097 compound
Apazone
Ethylene Oxide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
EFCAB2
SMYD2
DCAF1
SQSTM1
LYPLA1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
A Cross-Sectional Analysis of Receptor for Advanced Glycation End Products in Human Skeletal Muscle:…
Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Disease…
Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidn…
Identification of CD105 (endoglin) as novel risk marker in CLL.
The role of advanced glycation end products in vascular aging: which parameter is the most suitable …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer
Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer
A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes
A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Squamous Non-Sm…
CD160 Expression in Retinal Vessels is Associated With Retinal Neovascular Diseases
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ